comparemela.com

Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) has announced a new underwritten offering of 66.66 million units to one of its largest institutional shareholders as well as new institutional investors.

Related Keywords

,Fund Agreement Gets ,Cybin Inc ,Neo Exchange ,Alliance Global Partners ,Lincoln Park Capital Fund ,Cboe Canada ,Agreement Gets ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.